Scarica l'app Stockscreener
62.02
2.01%
1.178
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$60.84
Aprire:
$61.05
Volume 24 ore:
1.39M
Relative Volume:
0.25
Capitalizzazione di mercato:
$30.65B
Reddito:
$198.10B
Utile/perdita netta:
$-6.45B
Rapporto P/E:
-4.7182
EPS:
-13.1443
Flusso di cassa netto:
$7.11B
1 W Prestazione:
-2.13%
1M Prestazione:
-3.32%
6M Prestazione:
+43.26%
1 anno Prestazione:
+138.06%
Intervallo 1D:
$60.48
$62.31
Intervallo di 1 settimana:
$56.67
$64.95
Portata 52W:
$25.07
$69.36
Centene Corp Stock (CNC) Company Profile
Nome
Centene Corp
Settore
Industria
Telefono
(314) 725-4477
Indirizzo
7700 FORSYTH BLVD., ST LOUIS
Compare CNC vs UNH, CVS, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
62.07 | 31.64B | 198.10B | -6.45B | 7.11B | -13.14 |
UNH
Unitedhealth Group Inc
|
419.71 | 379.28B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
105.36 | 136.61B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
377.65 | 82.05B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
282.88 | 76.98B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
367.20 | 45.76B | 137.20B | 1.15B | 1.27B | 9.3439 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-10-14 | Iniziato | Goldman | Sell |
| 2025-07-28 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-07-21 | Downgrade | TD Cowen | Buy → Hold |
| 2025-07-16 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-07-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-07-02 | Downgrade | UBS | Buy → Neutral |
| 2025-06-09 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-02 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-04-08 | Aggiornamento | Jefferies | Underperform → Hold |
| 2025-02-06 | Downgrade | Argus | Buy → Hold |
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-12-13 | Aggiornamento | UBS | Neutral → Buy |
| 2024-12-10 | Downgrade | Jefferies | Hold → Underperform |
| 2024-07-24 | Downgrade | Jefferies | Buy → Hold |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-03-21 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2024-01-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-09-05 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-08-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-06-20 | Iniziato | UBS | Neutral |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-03-08 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-02-23 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-13 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-09-30 | Iniziato | Argus | Buy |
| 2022-08-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-07-28 | Ripresa | Barclays | Overweight |
| 2022-07-14 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-06-21 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Ripresa | Bernstein | Outperform |
| 2022-05-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-01-07 | Ripresa | Barclays | Overweight |
| 2022-01-06 | Ripresa | JP Morgan | Overweight |
| 2021-12-14 | Iniziato | Goldman | Neutral |
| 2021-12-13 | Reiterato | BMO Capital Markets | Outperform |
| 2021-12-13 | Reiterato | BofA Securities | Buy |
| 2021-12-13 | Reiterato | Credit Suisse | Neutral |
| 2021-12-13 | Reiterato | Mizuho | Neutral |
| 2021-12-13 | Reiterato | Oppenheimer | Outperform |
| 2021-12-13 | Reiterato | Stephens | Overweight |
| 2021-12-13 | Reiterato | Truist | Buy |
| 2021-12-13 | Reiterato | Wells Fargo | Overweight |
| 2021-12-13 | Reiterato | Wolfe Research | Outperform |
| 2021-11-01 | Downgrade | Citigroup | Buy → Neutral |
| 2021-09-10 | Iniziato | Cowen | Outperform |
| 2021-07-09 | Iniziato | Seaport Global Securities | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Overweight |
| 2021-05-11 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-03-10 | Iniziato | Mizuho | Neutral |
| 2021-01-21 | Ripresa | Goldman | Neutral |
| 2021-01-15 | Downgrade | Jefferies | Buy → Hold |
| 2020-09-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Iniziato | SVB Leerink | Outperform |
| 2020-02-05 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-02-03 | Ripresa | Evercore ISI | Outperform |
| 2020-01-28 | Reiterato | Bernstein | Outperform |
| 2020-01-06 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-05-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-01-14 | Iniziato | Stephens | Overweight |
| 2018-10-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-07-18 | Ripresa | Citigroup | Neutral |
| 2017-12-18 | Reiterato | Jefferies | Buy |
| 2017-09-13 | Reiterato | Leerink Partners | Mkt Perform |
| 2017-06-07 | Iniziato | Morgan Stanley | Overweight |
| 2017-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-04-05 | Iniziato | Deutsche Bank | Buy |
| 2017-03-23 | Downgrade | Citigroup | Buy → Neutral |
| 2017-02-08 | Reiterato | Barclays | Overweight |
| 2017-02-07 | Ripresa | Cantor Fitzgerald | Overweight |
| 2017-01-04 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Centene Corp Borsa (CNC) Ultime notizie
Centene flags weakening Medicaid membership, shares fall By Reuters - Investing.com
Centene Slides as Investors Look Past Q2 Beat to Membership and Outlook Quality - Quiver Quantitative
Centene posts $1 billion profit, up from $253 million loss a year ago - The Business Journals
Centene CEO Lowers Year-End Membership Outlook - scanx.trade
Earnings call transcript: Centene beats Q2 2026 forecasts, but shares fall - Investing.com
Centene Corporation Reports Strong Q2 2026 Results, Raises Full-Year EPS and Revenue Guidance - Minichart
Centene (CNC) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Centene Raises Full-Year Outlook After Strong Second-Quarter Earnings Beat - Yahoo Finance
[10-Q] CENTENE CORP Quarterly Earnings Report - Stock Titan
Centene (CNC) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
Centene announces board changes with Burdick retirement - Investing.com
CNC Looks 23.0% Undervalued on GF Value™ Amid Strong Q2 Revenue Beat - GuruFocus
Is Centene Corp (CNC) Undervalued After Q2 Earnings Beat? EPS of $2.51 Surpasses Estimates; GF Score: 71/100 - GuruFocus
Centene shares gain 3% on beating estimates, raising guidance By Investing.com - Investing.com South Africa
CNC Looks 23.0% Undervalued on GF Value™ - GuruFocus
Centene Corp Q2 2026: Revenue $53.6B, Net income $1.09B, EPS $2.19— 10-Q Summary - TradingView
Centene Boosts Guidance, Reports Favorable Medical Costs - Bloomberg
Centene: Q2 Earnings Snapshot - marketscreener.com
Centene reports $53.6 billion in second quarter revenue - Quiver Quantitative
Centene Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Centene Market Sentiment - Benzinga España
Centene earnings on deck as investors eye Medicaid margin trends By Investing.com - Investing.com
Centene Corp (CNC) Income Statement - TradingKey
CNC|Centene Corp|Price:64.020|Chg%:+0.610 - TradingKey
Centene Corp (CNC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Centene Corp (CNC) Balance Sheet - TradingKey
What To Expect From Centene’s (CNC) Q2 Earnings - Barchart.com
CNC|Centene Corp|Price:63.410|Chg%:-0.330 - TradingKey
Centene stock holds steady as Medicaid membership and revenue guidance frame investor focus - Ad-hoc-news.de
Centene Corp Lobbyists, 2024 - OpenSecrets
Centene stock remains anchored by Medicaid scale and earnings - Ad-hoc-news.de
Ex-Centene VP claims company used records access as pretext to replace her with younger hire - The Business Journals
Centene stock trades with earnings pressure and Medicaid shifts - Ad-hoc-news.de
Centene Corp (CNC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Is Centene Corp (CNC) a Bargain After 3.3% Drop? GF Value Says U - GuruFocus
Centene Corp. stock underperforms Thursday when compared to competitors - MarketWatch
10 Health Care Stocks With Whale Alerts In Today’s Session - Benzinga
Centene (CNC) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
Centene stock trades steady as Medicaid membership and earnings shape outlook - Ad-hoc-news.de
Centene Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Centene accused of age discrimination by ousted VP - STLtoday.com
Is Centene Stock a Smart Buy Ahead of Q2 Earnings? Key Estimates - Yahoo Finance
Centene stock reflects managed care earnings power as Medicaid shift continues - Ad-hoc-news.de
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
Centene stock trades steady as Medicaid membership returns to growth - AD HOC NEWS
Cognizant Lands Centene Mega Deal Worth Over $500 Mn: Report - analyticsindiamag.com
Cognizant Wins Multi-Year Centene Deal That Could Touch $1 Billion - outlookbusiness.com
Cognizant bags over $500 million Centene deal, deepens AI push in healthcare - Storyboard18
Cognizant bags mega deal from Centene, likely worth over $500 million - Moneycontrol.com
Smart Money Is Buying Centene Corp. (CNC) - The Acquirer's Multiple
Centene (NYSE: CNC) grants 3,155 restricted stock units to director Tyler - Stock Titan
Centene Corp Azioni (CNC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.60%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):